Here's the latest horror to hit the shops in time for Halloween this year:
Form an orderly queue please, everyone.
Dechra Veterinary Products has announced the reintroduction of Gelofusine®, a collodial plasma volume substitute used in the management of hypovolaemic shock in cats, dogs and horses. The company says that Gelofusine has the added advantage of containing no calcium and is therefore compatible with blood and blood products. Gelofusine is isooncotic (same colloid oncotic pressure) with plasma and therefore volume replacement is equivalent to the volume infused. Thus there is no danger of volume overload, as exists when using a plasma expander. Each bottle comes with a Free Dual Giving Set (worth £3.35), featuring a dual sectional dial with a 10%-40% scale for colloids.
SMITHS Detection, part of the global technology business Smiths Group, today announces it is to launch a portable detection system that will enable veterinarians to carry out on-site diagnosis of animal diseases such as foot-and-mouth and avian flu.
This new technology means vets will be able to diagnose diseases in livestock and birds in the field in less than 90 minutes rather than having to send samples for laboratory analysis.
The new system will be launched to vets at the World Association of Veterinary Laboratory Diagnosticians conference in Australia in November 2007 and is expected to be in production in mid 2008.
Dechra Veterinary Products is celebrating sales of 100 million sachets of Equipalazone® Powder with a campaign in which customers will get a special deal, and the chance to enter a draw for a VIP, 3-day trip to Badminton 2008.
VRCC veterinary referral centre, the leading European veterinary cancer treatment centre, has announced that it has installed what is believed to be the first and only new 'Human' CT scanner in a UK private small animal veterinary centre, at a cost of nearly £500,000. The announcement came less than a year after the centre's 6 million volt linear accelerator went online - currently the only veterinary radiotherapy facility in the UK. Apart from routine scans required by all the clinicians at the centre, VRCC also takes referrals in medicine, surgery and oncology. Its CT will also be used in conjunction with the linear accelerator, offering sophisticated cancer treatments previously not available in the UK. In another first for VRCC, the centre has appointed Tom Jackson BSc Radiography (T), a therapeutic radiographer from Guys & St Thomas Westminster, a centre of excellence in oncology. Tom will be working under the direction of the centre's clinical director, Dr Susan North, the most highly qualified and experienced veterinary oncologist in the UK and the only qualified radiation veterinary oncologist in the UK.
For more information about the referral services available from VRCC, visit http://www.vrcc.co.uk/, or ring 01268 564664.
Vetoquinol UK has launched Marbocyl Solo – a one shot treatment for Bovine Respiratory Disease. Marbocyl Solo is a 100mg/ml solution of marbofloxacin given as one injection IM at 8mg/kg. It treats sick animals fast, killing bacteria in one go, therefore minimising lung damage and consequential morbidity. This fast action reduces the risk of the spread of infection. On top of that, Marbocyl Solo has a meat withdrawal of only 3 days (milk 3 days). “Marbocyl is a well proven antibacterial that is extensively used in cattle practice,” explains Alvin Cerely, Marbocyl’s product manager. “Marbocyl Solo is exceptionally well placed for applying ‘concentration killing’ or a‘strike action’ strategy as opposed to a ‘long action’ strategy used by other antibiotics. Marbocyl Solo is available as a separate presentation to Marbocyl 10% to avoid confusion, particularly with farmers, on different dosage regimes and withdrawal periods.”
Marbocyl Solo is available now and details have been mailed to all cattle vets in the UK and Ireland. Please contact your Vetoquinol representative or telephone 0800 169 8197 for more details.